Conditional economic incentives to improve HIV treatment adherence: Literature review and theoretical considerations

AIDS and Behavior

Volumn 17, Issue 7, 2013, Pages 2283-2292

  Galárraga, Omar ^a   Genberg, Becky L ^a   Martin, Rosemarie A ^a   Barton Laws, M ^a   Wilson, Ira B ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Adherence to medication; Antiretroviral HIV treatment; Conditional cash transfers; Contingency management; Economic incentives

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CLINICAL TRIAL (TOPIC); DRUG MONITORING; ECONOMICS; HABIT; HIV INFECTIONS; HUMAN; MEDICATION COMPLIANCE; MOTIVATION; PERSONAL AUTONOMY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REINFORCEMENT; SOCIOECONOMICS; THERAPY; VULNERABLE POPULATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PSYCHOLOGICAL ASPECT; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CLINICAL TRIALS AS TOPIC; DRUG MONITORING; HABITS; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; MOTIVATION; PERSONAL AUTONOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIOECONOMIC FACTORS; THERAPEUTICS; TOKEN ECONOMY; VULNERABLE POPULATIONS;

EID: 84882639804     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0415-2     Document Type: Article

References (74)

1. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450-4.
2. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS clinical trials group 320 study team. N Engl J Med. 1997;337(11):725-33.
3. Hirsch M, Steigbigel R, Staszewski S, et al. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis. 1999;180(3):659-65.
4. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-3.
5. Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515-21.
6. Haug NA, Sorensen JL, Gruber VA, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006;30(6):752-81.
7. Haug NA, Sorensen JL. Contingency management interventions for HIV-related behaviors. Curr HIV/AIDS Rep. 2006;3(4):154-9.
8. Rosen MI, Dieckhaus K, McMahon TJ, et al. Improved adherence with contingency management. AIDS Patient Care STDs. 2007;21(1):30-40.
9. Sorensen JL, Haug NA, Delucchi KL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88(1):54-63.
10. Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888-96.
11. Defulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;. doi: 10.1016/j.ypmed.2012.04.017.
12. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58(2-Jan):55-66.
13. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192-203.
14. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. J Subst Abuse Treat. 2006;101(11):1546-60.
15. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179-87.
16. Higgins ST, Silverman K, Heil SH, editors. Contingency management in substance abuse treatment. New York: Guilford Press; 2008.
17. Dallery J, Meredith SE, Budney AJ. Contingency management in substance abuse treatment. In: Walters ST, Rotgers F, editors. Treating substance abuse: theory and technique. 3rd ed. New York: Guilford Press; 2012.
18. Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315(7110):703-7.
19. Fiszbein A, Schady N, Ferreira FHG. Conditional cash transfers: reducing present and future poverty [Chapter 2: Economic Rationale]. Washington D.C.: World Bank; 2009.
20. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415-7.
21. Rabin M. Psychology and economics. J Econ Lit. 1998;36(1):11-46.
22. DellaVigna S. Psychology and economics: evidence from the field. J Econ Lit. 2009;47(2):315-72.
23. Frederick S, Loewenstein G, O'Donoghue T. Time discounting and time preference: a critical review. J Econ Lit. 2002;40(2):351-401.
24. Laibson D. Golden eggs and hyperbolic discounting. Q J Econ. 1997;112(2):443-77.
25. Zimbardo PG, Boyd JN. Putting time in perspective: a valid, reliable individual-differences metric. J Pers Soc Psychol. 1999;77(6):1271-88.
26. Boyd JN, Zimbardo PG. Time perspective, health, and risk taking. In: Strathman A, Joireman J, editors. Understanding behavior in the context of time: theory, research, and application. Mahwah: Lawrence Erlbaum Associates; 2005.
27. Murphy JG, MacKillop J, Vuchinich RE, Tucker JA. The behavioral economics of substance abuse. In: Walters ST, Rotgers F, editors. Treating substance abuse: theory and technique. 3rd ed. New York: Guilford; 2012.
28. Marshall A. Principles of economics. London and New York: Macmillan; 1890.
29. Strecher VJ, Rosenstock IM. The health belief model. In: Glanz K, Lewis FM, editors. Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass; 1997.
30. Deci EL, Ryan RM. A motivational approach to self: integration in personality. Nebr Symp Motiv. 1990;38:237-88.
31. Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627-68. discussion 692-700.
32. Ryan RM, Deci EL. Intrinsic and extrinsic motivations: classic definitions and new directions. Contemp Educ Psychol. 2000;25(1):54-67.
33. Deci EL, Ryan RM. The "what" and "why" of goal pursuits: human needs and the self-determination of behavior. Psychol Inq. 2000;11(4):227-68.
34. Deci EL, Ryan RM. Self-determination theory: a macrotheory of human motivation, development, and health. Can Psychol. 2008;49(3):182-5.
35. Rigby CS, Deci EL, Patrick BC, Ryan RM. Beyond the intrinsic extrinsic dichotomy - self-determination in motivation and learning. Motiv Emotion. 1992;16(3):165-85.
36. Cameron J. Negative effects of reward on intrinsic motivation - A limited phenomenon: comment on Deci, Koestner, and Ryan (2001). Rev Educ Res. 2001;71(1):29-42.
37. Cameron J, Banko KM, Pierce WD. Pervasive negative effects of rewards on intrinsic motivation: the myth continues. Behav Analyst. 2001;24(1):1-44.
38. Pierce WD, Cameron J, Banko KM, So S. Positive effects of rewards and performance standards on intrinsic motivation. Psychol Rec. 2003;53:561-79.
39. Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol. 2009;64(6):527-37.
40. Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17(3):269-76.
41. Ryan RM, Deci EL. Self-regulation and the problem of human autonomy: does psychology need choice, self-determination, and will? J Pers. 2006;74(6):1557-85.
42. DiIorio C, McCarty F, Resnicow K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273-83.
43. Bandura A. Social learning theory. Englewood Cliffs: Prentice Hall; 1977.
44. Azjen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs: Prentice-Hall; 1980.
45. Prochaska JO, Norcross JC, DiClemente CC. Changing for good: the revolutionary program that explains the six stages of change and teaches you how to free yourself from bad habits. New York: W. Morrow; 1994.
46. Prochaska JO, DiClemente CC. The transtheoretical approach: crossing traditional boundaries of therapy. Homewood: Dow Jones-Irwin; 1984.
47. Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend. 2004;74(1):1-13.
48. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80-94.
49. Farmer P. Social scientists and the new tuberculosis. Soc Sci Med. 1997;44:347-58.
50. Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr. 2009;52(4):465-73.
51. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74-81.
52. Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159-69.
53. Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDs. 2009;23(8):603-9.
54. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207-18.
55. Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11.
56. Bandura A. Human agency in social cognitive theory. Am Psychol. 1989;44(9):1175-84.
57. Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation- behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193-203.
58. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation- behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462-73.
59. Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4:167-82.
60. Charmaz K. Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn. 1983;5:168-95.
61. Aujoulat I, Marcolongo R, Bonadiman L, Deccache A. Reconsidering patient empowerment in chronic illness: a critique of models of self-efficacy and bodily control. Soc Sci Med. 2008;66:1228-39.
62. Baumgartner LM. The incorporation of the HIV/AIDS identity into the self over time. Qual Health Res. 2007;17:919-31.
63. Serpe RT. Stability and change in self: a structural symbolic interactionist explanation. Soc Psychol Q. 1987;50:44-55.
64. Auld MC. Disentangling the effects of morbidity and life expectancy on labor market outcomes. Health Econ. 2002;11(6):471-83.
65. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Int Med. 2000;15(12):841-7.
66. Javanbakht M, Prosser P, Grimes T, Weinstein M, Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J Int Phys AIDS Care. 2006;5(4):143-50.
67. Charness G, Gneezy U. Incentives to exercise. Econometrica. 2009;77(3):909-31.
68. Roll JM, Higgins ST, Badger GJ. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal. 1996;29(4):495-504. quiz 504-5.
69. Deren S, Stephens R, Davis WR, Feucht TE, Tortu S. The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Rep. 1994;109(4):548-54.
70. Kamb ML, Rhodes F, Hoxworth T, et al. What about money? Effect of small monetary incentives on enrollment, retention, and motivation to change behaviour in an HIV/STD prevention counselling intervention. The Project RESPECT Study Group. Sex Transm Infect. 1998;74(4):253-5.
71. Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44-51.
72. McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012;26(14):1735-8.
73. Benabou R, Tirole J. Intrinsic and extrinsic motivation. Rev Econ Stud. 2003;70(3):489-520.
74. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.